Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:
Back to home » Top Stories » IAC 2008
IAC 2008 XVII International AIDS Conference
Mexico City, Mexico
August 3-8, 2008

IAC Panelists: Scale Up, Leadership and Youth Crucial to HIV Response

August 4, 2008

By Tim Horn

The first major session of the XVII International AIDS Conference in Mexico City, held on Monday morning, August 4, provided an assessment of recent advancements and challenges toward the scale up of HIV treatment and prevention programs, along with calls for greater leadership and an urgent youth HIV/AIDS agenda.

Building on Progress to Date

Jaime Sepulveda, MD, founder of Mexico’s National AIDS Council, who is now with the Bill & Melinda Gates Foundation, noted that resources for AIDS are at all-time highs, including substantially increased funding for the Global Fund and the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR).

According to Sepulveda, reaching the goal of 3 million people in low- and middle-income countries on treatment at the end of 2007 was a critical step forward, but he says that the world has only scratched the surface of possibilities in responding to the epidemic.

Greater resources, more effectively spent and targeted where they can have the greatest effect, would have a dramatic impact on the epidemic’s course. Highlighting the fact that more people became infected with HIV last year than began treatment, Sepulveda called for radically increased investments in prevention research, evaluation and delivery of services, as well as accelerated research on promising prevention methods, including a vaccine.

In conclusion, he reiterated that political leadership from all countries and accountability at all levels are essential to stop the epidemic.
 
Leadership Key to Success 

Citing the results in both treatment and prevention scale up in countries with sustained leadership, such as Rwanda and Tanzania, Alex Coutinho, MD, of the Infectious Disease Institute of Makerere University in Kampala, Uganda, made a passionate call for greater leadership as a path toward meeting the challenges ahead.

In looking at progress to date, Coutinho first highlighted the effectiveness of mother-to-child transmission (PMTCT) programs for pregnant women. Approximately 33 percent of HIV-positive pregnant women were enrolled in a PMTCT program last year, which include the provision of HIV drug treatment to help prevent transmission of the virus during pregnancy and delivery. In 2004, Coutinho said, only 10 percent of women had access to such programs.

Children also continue to benefit from the scale-up of treatment access initiatives. In 2005, only 75,000 children in low-income countries had access to antiretroviral therapy. Last year, approximately 200,000 children were receiving life-saving HIV treatment.

In contrast, he noted that most countries will not achieve universal access by 2010 and that the majority of people living with HIV are still unaware of their HIV status. In his call to action, Coutinho urged greater investment in prevention; financial resources flexible enough to support health systems; and systems that access rural and other hard-to-reach areas and fully embrace people living with HIV/AIDS as partners.

Coutinho also urged outreach to and support of marginalized and at-risk communities, as well as the greater involvement of people living with HIV as a catalyst for change.
 
Inclusion of Youth Essential 

Elisabet Fadul of the Dominican Network for Youth Rights in the Dominican Republic outlined a broad and urgent youth HIV/AIDS agenda, calling for comprehensive rights- and evidence-based plans to provide access for young people.

Highlighting the 40 percent of new infections worldwide among young people between ages 15 and 24, Fadul noted that HIV prevention and treatment programs are failing to effectively reach young people, with the most vulnerable and marginalized being stigmatized, criminalized or forgotten by many of these programs.
 
To reverse this course, she called for actions and policies that engage youth, especially young people living with HIV/AIDS, as respected partners in developing and implementing programs that forthrightly address their needs and diversity.
 

Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

comments 1 - 1 (of 1 total)    

JOHN C. HOPKINS, ATLANTA, GA., 2008-08-06 16:10:28
Dr. Sepulveda speaks of worldwide resources being at an all time high with the increase of PEPFAR funds. While here in the USA we are suffering budget cuts and funding shortfalls. In the face of CDC new numbers indicating an undercount of the problem in the USA. THIS IS MADNESS.

comments 1 - 1 (of 1 total)    

Our general International AIDS Conference coverage is made possible with a charitable grant from Bristol-Myers Squibb.

More from IAC 2008

Starting and Switching Treatment

August 12, 2008
Isentress, Intelence and Prezista Combo Shines for Treatment Veterans
Studies Disagree on Abacavir for Patients With High Viral Loads
August 6, 2008
Isentress Continues to Show Well Versus Sustiva as First-Line Treatment
Stigma, Fear of Side Effects, Keep Many off Treatment
Sustiva Bests Kaletra for Treatment of Advanced HIV Disease
August 5, 2008
Some Gender and Racial Differences with Three Protease Inhibitors
August 4, 2008
Similar Survival Among IDUs on ARV Treatment

HIV/AIDS Complications

August 15, 2008
Milk Thistle Shows Potential for Hep C
August 14, 2008
Defining the Risk Factors for Kidney Damage in Patients Using Tenofovir
August 13, 2008
Encouraging Data From Second Tesamorelin Study for Lipo
August 11, 2008
Abacavir and Cardiovascular Risk: Is There or Isn’t There?
August 7, 2008
Abacavir and Heart Attack Risk: Round 2
August 6, 2008
Hep C: The Other Epidemic

Experimental HIV Drugs

August 15, 2008
Norvir Tablets Similar to Capsules, Expected in 2009
August 12, 2008
Future Options for the Treatment Experienced
New Options for Those New to Treatment
August 11, 2008
IDX899 Safe, Reduces Viral Load in Preliminary Study
August 8, 2008
New NNRTI RDEA806 Shows Promise in Seven-Day Study
August 6, 2008
NNRTI Rilpivirine (TMC-278) Comparable to Sustiva in 96-Week Study

HIV Transmission and Prevention

August 18, 2008
Vaccines: Lessons Learned
August 15, 2008
PrEP: Preparing For Success?
August 14, 2008
New HIV Numbers: New Prevention Strategy? Part 1
New HIV Numbers: New Prevention Strategy? Part 2
August 7, 2008
Microbicides: Assessing Progress
Having Children a Priority for Many Positive Women
August 5, 2008
Report: Now Is Time to Prepare for PrEP
August 3, 2008
Annual HIV Infections in U.S. Substantially Higher Than Believed

Global HIV/AIDS

August 19, 2008
AIDS Activism For The Next Decade
August 15, 2008
Human Rights Struggles Define AIDS Fight
August 8, 2008
Achieving Universal Treatment Access: The Experience in Rural Malawi
August 6, 2008
Stigma, Fear of Side Effects, Keep Many off Treatment
August 4, 2008
Shortage of Health Care Workers Threatens African HIV Care
IAC Panelists: Scale Up, Leadership and Youth Crucial to HIV Response

Regan's Blog

August 6, 2008
La Voz Global
August 4, 2008
Bienvenidos a AIDS 2008!


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertise/contact us]

© 2008 Smart + Strong. All Rights Reserved. terms of use and your privacy